Search

The North American Pharmacist Licensure Examination (NAPLEX) is a major assessment metric for graduates pursuing licensure and the institutions from which they graduated. Before 2014, the mean NAPLEX first‐time pass rate was roughly 95% every year. Mean pass rates have fallen dramatically since then to less than 80%, with many schools currently unable to achieve a 70% pass rate. Such a drastic decline in NAPLEX performance constitutes a crisis for many schools. Changes to the exam blueprint, administration, and scoring provide a partial explanation for the decline, but the issue of cause ultimately comes down to one simple question: What has changed over the last 10 years that is making it more difficult for graduates to pass NAPLEX on the first attempt? The effects of excessive academic expansion, beginning in 2000, cannot be overlooked. The newest schools, established after 2009, and accelerated (3‐year) programs, many of which are also new, appear to be particularly vulnerable. In 2023, 16 pharmacy schools had first‐time pass rates below 65%. Nine (56%) of those schools opened after 2009 and seven (44%) were accelerated programs. Newer schools have had to compete for a limited supply of qualified faculty, administrators, preceptors and experiential training sites, while also striving to meet enrollment targets amid a dwindling applicant pool. The ability to overcome the NAPLEX crisis depends on first establishing a more effective process of assessing NAPLEX results—one that measures the right metrics in the right way—and upholds fair, but rigorous, quality standards. Stakeholders need access to actionable information and the most relevant, useful data available. The purpose of this article is to provide evidence that the Academy is facing a legitimate crisis and offer four recommendations by which assessment and understanding of the crisis can be enhanced. [ABSTRACT FROM AUTHOR]

It's any pharmacy students dream to practice their profession in the United States (US) because it stands out in providing dignity and the remuneration it pays off to the pharmacist than any other country in the world. Foreign pharmacy graduate equivalent examination (FPGEE) certification is mandated to all the foreign pharmacists as a first step to practice pharmacy profession in the United States of America. After the new requirement mandated in the US from 2003, Pharmacy Council of India launched doctor of pharmacy as a 6 years integrated course to help the college ready students and a 3 year post-baccalaureate bridge course for the students graduated after 2003 as an intervention in 2008. Even though the process is so laborious most of the foreign graduates think it's worth taking a shot. It starts off with applying for transcripts and ends with taking up the FPGEE held by the National Association of Board of Pharmacy (NABP). Obtaining eligibility for the exam is a laborious process that can take anywhere from 6 months to 1 year depending upon the university of graduation, country's pharmacy board/council, its reciprocation with the NABP and the country's postal transit. Despite fulfilling all the requirements accurately, the entry of the candidate into the country is not certain as it lies in the hands of the visa issuing offer whose actions are always unpredictable. [ABSTRACT FROM AUTHOR]